测试T1D青少年虚拟练习游戏的多种交付方法 (ExerT1D) 同行干预:协议开发和可行性
Hormone research in paediatrics
|February 16, 2026
概括
使用虚拟现实游戏和T1D教练的ExerT1D计划显示,对于1型糖尿病 (T1D) 的青少年来说,改善身体活动和自我管理技能是可行和可接受的.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 数字健康干预措施 数字健康干预措施
- 青少年健康 青少年健康
背景情况:
- 患有1型糖尿病 (T1D) 的青少年面临着适度至强度体力活动 (MVPA) 的重大障碍,包括自我管理挑战,缺乏支持性环境和与糖尿病相关的耻辱感.
- 青少年与T1D之间的同行参与和榜样支持的机会有限,阻碍了参与体育活动.
- 针对患有T1D的青少年的虚拟运动游戏 (ExerT1D) 计划是为了满足这些需求而开发的,通过代的改进来实现可行性和可接受性.
研究的目的:
- 测试ExerT1D程序的代改进的可行性和可接受性.
- 评估该计划在青少年中支持T1D自我管理和MVPA参与方面的潜力.
- 探索虚拟现实集成对参与者体验和结果的影响.
主要方法:
- 一个试点项目涉及6个版本的ExerT1D,包括主动视频游戏和虚拟现实 (VR) 活动视频游戏.
- 所有程序版本都包括T1D运动管理教育,由临床医生提供,以及T1D年轻成人教练的目标设定支持.
- 十七名患有T1D的青少年 (平均年龄15.4岁) 参与了这项研究,基于反的代设计变化.
主要成果:
- 参与者对该计划,临床医生,教练和小组凝聚力表示高度满意.
- 对视频游戏参与的动机很高,T1D/MVPA自我管理技能被评为优秀.
- 探索性分析表明HbA1c/葡萄糖管理指标 (GMI) 随着时间的推移而下降 (d=-1.12).
结论:
- "ExerT1D"计划成功地为患有T1D的青少年创造了一个支持性的环境,让他们参与MVPA,并由患有T1D的同龄人指导.
- 整合虚拟现实增强了沟通和同行互动,尽管有技术延迟.
- 需要进行更大规模的研究来证实干预措施对身体活动,血糖控制和生活质量的影响.
相关概念视频
Type I Diabetes I: Introduction
39
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
39
Type I Diabetes II: Pathophysiology
54
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
54
Type II Diabetes I: Introduction
8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8


